FDA Import Refusal AEK-9054875-9/10003/1 — Pfizer Canada
The FDA refused shipment AEK-9054875-9/10003/1 from Pfizer Canada (Canada) on January 9, 2026. The refused product falls under Drugs and Biologics — APIXABAN (ANTI-COAGULANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- January 9, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61LCA44 APIXABAN (ANTI-COAGULANT)
- Charges
- 75